Sintx Technologies has earned FDA 510(k) clearance for its SINAPTIC Foot & Ankle Osteotomy Wedge System.
The implant system combines a silicon nitride biomaterial, surgeon-informed implant designs and a single-use instrument kit, according to an Oct. 20 news release from the company.
Sintx aims to increase surgical efficiency, precision and predictability with its implant system.
The company is planning a U.S. commercial launch in the first quarter of 2026, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
